Inhibition of tumor necrosis factor-alpha production by orally administering a perilla leaf extract

被引:35
作者
Ueda, H [1 ]
Yamazaki, M [1 ]
机构
[1] TEIKYO UNIV, FAC PHARMACEUT SCI, DEPT MED CHEM, SAGAMIKO, KANAGAWA 19901, JAPAN
关键词
tumor necrosis factor-alpha; Perilla frutescens;
D O I
10.1271/bbb.61.1292
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The overproduction of tumor necrosis factor-alpha (TNF-alpha) was suppressed by orally administering a perilla leaf extract (PLE). When mice were successively injected with OK-132, severe TNF-alpha was induced in the serum, but this elevated TNF-alpha level was reduced after an oral administration of PLE (400 mu l/mouse), Oral administration of PLE also inhibited TNF-alpha production that was induced by muramyl dipeptide (500 mu g/mouse) and OK-432 (3 KE/mouse). These characteristics were obtained from all strains of perilla, The inhibitory activity against TNF-alpha production was heat-stable, and the existence of several active molecules was suggested, When PLE was passed through an ultrafilter, the inhibitory activity against TNF-alpha production was collected in those fractions with a mass of 0.5 to 1 kDa and more than 10 kDa, When PLE was solvent-extracted, the strongest activity was recognized with aqueous preparation, although significant activity was also detected in preparations extracted with n-hexane and ethyl acetate. These findings suggest that the daily use of certain functional foods may be useful for controlling the host defense system.
引用
收藏
页码:1292 / 1295
页数:4
相关论文
共 21 条
[1]   ENDOTOXIN-INDUCED SERUM FACTOR THAT CAUSES NECROSIS OF TUMORS [J].
CARSWELL, EA ;
OLD, LJ ;
KASSEL, RL ;
GREEN, S ;
FIORE, N ;
WILLIAMSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (09) :3666-3670
[2]   THE ROLE OF CACHECTIN/TNF IN ENDOTOXIC-SHOCK AND CACHEXIA [J].
CERAMI, A ;
BEUTLER, B .
IMMUNOLOGY TODAY, 1988, 9 (01) :28-31
[3]   ROSMARINIC ACID - A NEW INHIBITOR OF COMPLEMENT C3-CONVERTASE WITH ANTI-INFLAMMATORY ACTIVITY [J].
ENGLBERGER, W ;
HADDING, U ;
ETSCHENBERG, E ;
GRAF, E ;
LEYCK, S ;
WINKELMANN, J ;
PARNHAM, MJ .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1988, 10 (06) :729-737
[4]   ANTIBODIES TO CACHECTIN TUMOR NECROSIS FACTOR REDUCE INTERLEUKIN-1-BETA AND INTERLEUKIN-6 APPEARANCE DURING LETHAL BACTEREMIA [J].
FONG, YM ;
TRACEY, KJ ;
MOLDAWER, LL ;
HESSE, DG ;
MANOGUE, KB ;
KENNEY, JS ;
LEE, AT ;
KUO, GC ;
ALLISON, AC ;
LOWRY, SF ;
CERAMI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (05) :1627-1633
[5]  
FUKUMORI Y, 1995, NIPPON NOGEIKAGAKU K, V69, P911
[6]  
Imaoka Koichi, 1993, Japanese Journal of Allergology, V42, P74
[7]   PENTOXIFYLLINE THERAPY IN HIV-SEROPOSITIVE SUBJECTS WITH ELEVATED TNF [J].
KRUSE, A ;
RIENECK, K ;
KAPPEL, M ;
ORHOLM, M ;
BRUUNSGAARD, H ;
ULLUM, H ;
SKINHOJ, P ;
PEDERSEN, BK .
IMMUNOPHARMACOLOGY, 1995, 31 (01) :85-91
[8]   THALIDOMIDE INHIBITS THE REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
MAKONKAWKEYOON, S ;
LIMSONPOBRE, RNR ;
MOREIRA, AL ;
SCHAUF, V ;
KAPLAN, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :5974-5978
[9]  
NAKANISHI T, 1990, CHEM PHARM BULL, V38, P1772, DOI 10.1248/cpb.38.1772
[10]  
OKUTOMI T, 1990, J BIOL RESP MODIF, V9, P564